202 related articles for article (PubMed ID: 32153626)
41. Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
Wang LX; Wan C; Dong ZB; Wang BH; Liu HY; Li Y
Med Sci Monit; 2019 Apr; 25():2896-2907. PubMed ID: 31004080
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle-invasive bladder cancer.
Wang H; Niu L; Jiang S; Zhai J; Wang P; Kong F; Jin X
Oncotarget; 2016 Dec; 7(52):86174-86185. PubMed ID: 27863388
[TBL] [Abstract][Full Text] [Related]
43. Systematic Analysis to Identify the MIR99AHG-has-miR-21-5p-
He M; Zhang H; Zhang Y; Ding Y; Zhang F; Kang Y
J Cancer; 2024; 15(8):2391-2402. PubMed ID: 38495494
[TBL] [Abstract][Full Text] [Related]
44. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
[TBL] [Abstract][Full Text] [Related]
45. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
[TBL] [Abstract][Full Text] [Related]
46. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
47. Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
Lin YZ; Wu YP; Ke ZB; Cai H; Chen DN; Chen SH; Li XD; Lin TT; Huang JB; Zheng QS; Xue XY; Xu N; Wei Y
Med Sci Monit; 2020 Apr; 26():e920504. PubMed ID: 32277695
[TBL] [Abstract][Full Text] [Related]
48. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
49. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
51. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
Yao K; Wang Q; Jia J; Zhao H
Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
[TBL] [Abstract][Full Text] [Related]
52. Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
Xu Z; Wang C; Xiang X; Li J; Huang J
Med Sci Monit; 2019 Apr; 25():3041-3060. PubMed ID: 31020952
[TBL] [Abstract][Full Text] [Related]
53. Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network.
Ye G; Guo L; Xing Y; Sun W; Yuan M
Exp Ther Med; 2019 Apr; 17(4):3035-3040. PubMed ID: 30906477
[TBL] [Abstract][Full Text] [Related]
54. lncRNA OSTN-AS1 May Represent a Novel Immune-Related Prognostic Marker for Triple-Negative Breast Cancer Based on Integrated Analysis of a ceRNA Network.
Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
Front Genet; 2019; 10():850. PubMed ID: 31572452
[TBL] [Abstract][Full Text] [Related]
55. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Xu Y; Chen J; Yang Z; Xu L
Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
[TBL] [Abstract][Full Text] [Related]
56. Association of a novel seven-gene expression signature with the disease prognosis in colon cancer patients.
Yang H; Liu H; Lin HC; Gan D; Jin W; Cui C; Yan Y; Qian Y; Han C; Wang Z
Aging (Albany NY); 2019 Oct; 11(19):8710-8727. PubMed ID: 31612869
[TBL] [Abstract][Full Text] [Related]
57. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
58. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis.
Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W
Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410
[TBL] [Abstract][Full Text] [Related]
59. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
60. Corrigendum: Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer.
Wan J; Jiang S; Jiang Y; Ma W; Wang X; He Z; Wang X; Cui R
Front Genet; 2020; 11():361. PubMed ID: 32362911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
